Pre–Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis | Zendy

Richard Castillo | Zendy; Ngoc Trinh Thi Pham | Zendy; Edward Castillo | Zendy; S. Aso-González | Zendy; S. Jaweed Ansari | Zendy; Brian P. Hobbs | Zendy; Diana Palacio | Zendy; Heath D. Skinner | Zendy; Thomas Guerrero | Zendy

Open Access

Pre–Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis

Author(s) -

Richard Castillo,

Ngoc Trinh Thi Pham,

Edward Castillo,

S. Aso-González,

S. Jaweed Ansari,

Brian P. Hobbs,

Diana Palacio,

Heath D. Skinner,

Thomas Guerrero

Publication year - 2015

Publication title -

radiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.118

H-Index - 295

eISSN - 1527-1315

pISSN - 0033-8419

DOI - 10.1148/radiol.14140457

Subject(s) - medicine , common terminology criteria for adverse events , radiation therapy , confidence interval , receiver operating characteristic , nuclear medicine , lung cancer , fluorodeoxyglucose , logistic regression , retrospective cohort study , odds ratio , positron emission tomography

To examine the association between pre-radiation therapy (RT) fluorine 18 fluorodeoxyglucose (FDG) uptake and post-RT symptomatic radiation pneumonitis (RP).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research